Involvement of MicroRNAs and Their Potential Diagnostic, Therapeutic, and Prognostic Role in Hepatocellular Carcinoma

Overview

Journal J Clin Lab Anal

Publisher Wiley

Specialties Biomedical Engineering
Biotechnology
Pathology

Date 2022 Aug 29

PMID 36036748

Authors

Yilong Zhou

Fan Liu

Chunyang Ma

Qiong Cheng

Affiliations

Soon will be listed here.

Abstract

Background: Hepatocellular carcinoma (HCC) accounts for 85%-90% of primary liver cancer. MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression by targeting the 3'UTR of mRNA. Abnormal expression and regulation of miRNAs are involved in the occurrence and progression of HCC, and miRNAs can also play a role in the diagnosis and treatment of HCC as oncogenes or tumor suppressors.

Methods: In the past decades, a large number of studies have shown that miRNAs play an essential regulatory role in HCC and have potential as biomarkers for HCC. We reviewed the literature to summarize these studies.

Results: By reviewing the literature, we retrospected the roles of miRNAs in the development, diagnosis, treatment, and prognosis of HCC, and put forward prospects for the further research on miRNAs in the precision treatment of HCC.

Conclusion: MicroRNAs are important regulators and biomarkers in the occurrence, progression, outcome, and treatment of HCC, and can provide new targets and strategies for improving the therapeutic effect of HCC.

Citing Articles

Network pharmacology and bioinformatic integrative analysis reveals candidate gene targets and potential therapeutic of East Kalimantan propolis against hepatocellular carcinoma.

Kustiawan P, Siregar K, Jauhar M, Ramadhan D, Mardliyati E, Syaifie P Heliyon. 2024; 10(21):e39142.

PMID: 39524833 PMC: 11544044. DOI: 10.1016/j.heliyon.2024.e39142.

Construction and evaluation of a liver cancer risk prediction model based on machine learning.

Wang Y, Yang W, Du Q, Liu Z, Lu M, You C World J Gastrointest Oncol. 2024; 16(9):3839-3850.

PMID: 39350987 PMC: 11438789. DOI: 10.4251/wjgo.v16.i9.3839.

An ultrasensitive electrochemical biosensor with dual-amplification mode and enzyme-deposited silver for detection of miR-205-5p.

Xie X, Chen C, Chen W, Qin Y, Xiang S, Jiang J Mikrochim Acta. 2024; 191(9):545.

PMID: 39158763 DOI: 10.1007/s00604-024-06596-7.

The Role of the MiR-181 Family in Hepatocellular Carcinoma.

Chen J, Liu K, Vadas M, Gamble J, McCaughan G Cells. 2024; 13(15.

PMID: 39120319 PMC: 11311592. DOI: 10.3390/cells13151289.

Recent Advances in Biosensor Technology for Early-Stage Detection of Hepatocellular Carcinoma-Specific Biomarkers: An Overview.

Chinnappan R, Makhzoum T, Arai M, Hajja A, Abul Rub F, Alodhaibi I Diagnostics (Basel). 2024; 14(14).

PMID: 39061656 PMC: 11276200. DOI: 10.3390/diagnostics14141519.

References

Switlik W, Bielecka-Kowalska A, Karbownik M, Kordek R, Jablkowski M, Szemraj J . Forms of diagnostic material as sources of miRNA biomarkers in hepatocellular carcinoma: a preliminary study. Biomark Med. 2019; 13(7):523-534. DOI: 10.2217/bmm-2018-0485. View

Colak S, Ten Dijke P . Targeting TGF-β Signaling in Cancer. Trends Cancer. 2017; 3(1):56-71. DOI: 10.1016/j.trecan.2016.11.008. View

He S, Tang S . WNT/β-catenin signaling in the development of liver cancers. Biomed Pharmacother. 2020; 132:110851. DOI: 10.1016/j.biopha.2020.110851. View

Hong D, Kang Y, Borad M, Sachdev J, Ejadi S, Lim H . Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours. Br J Cancer. 2020; 122(11):1630-1637. PMC: 7251107. DOI: 10.1038/s41416-020-0802-1. View

Nasser M, Zayed N, Mohamed A, Attia D, Esmat G, Khairy A . Circulating microRNAs (miR-21, miR-223, miR-885-5p) along the clinical spectrum of HCV-related chronic liver disease in Egyptian patients. Arab J Gastroenterol. 2019; 20(4):198-204. DOI: 10.1016/j.ajg.2019.11.003. View

Ji L, Lin Z, Wan Z, Xia S, Jiang S, Cen D . miR-486-3p mediates hepatocellular carcinoma sorafenib resistance by targeting FGFR4 and EGFR. Cell Death Dis. 2020; 11(4):250. PMC: 7170966. DOI: 10.1038/s41419-020-2413-4. View

Li C, Zhou D, Hong H, Yang S, Zhang L, Li S . TGFβ1- miR-140-5p axis mediated up-regulation of Flap Endonuclease 1 promotes epithelial-mesenchymal transition in hepatocellular carcinoma. Aging (Albany NY). 2019; 11(15):5593-5612. PMC: 6710057. DOI: 10.18632/aging.102140. View

Zhou H, Fang J, Shang L, Zhang Z, Sang Y, Xu L . MicroRNAs miR-125b and miR-100 suppress metastasis of hepatocellular carcinoma by disrupting the formation of vessels that encapsulate tumour clusters. J Pathol. 2016; 240(4):450-460. DOI: 10.1002/path.4804. View

Lv T, Kong L, Jiang L, Wu H, Wen T, Shi Y . Dicer1 facilitates liver regeneration in a manner dependent on the inhibitory effect of miR-21 on Pten and Rhob expression. Life Sci. 2019; 232:116656. DOI: 10.1016/j.lfs.2019.116656. View

10.

Sun L, Wang L, Chen T, Yao B, Wang Y, Li Q . microRNA-1914, which is regulated by lncRNA DUXAP10, inhibits cell proliferation by targeting the GPR39-mediated PI3K/AKT/mTOR pathway in HCC. J Cell Mol Med. 2019; 23(12):8292-8304. PMC: 6850956. DOI: 10.1111/jcmm.14705. View

11.

Liu H, Tan H, Lin Y, Xu B, Zhao W, Xie Y . MicroRNA-1271-5p inhibits cell proliferation and enhances radiosensitivity by targeting CDK1 in hepatocellular carcinoma. J Biochem. 2020; 167(5):513-524. DOI: 10.1093/jb/mvz114. View

12.

Huang S, He X, Ding J, Liang L, Zhao Y, Zhang Z . Upregulation of miR-23a approximately 27a approximately 24 decreases transforming growth factor-beta-induced tumor-suppressive activities in human hepatocellular carcinoma cells. Int J Cancer. 2008; 123(4):972-8. DOI: 10.1002/ijc.23580. View

13.

Liu H, Tang T, Hu X, Tan W, Zhou P, Zhang H . miR-138-5p Inhibits Vascular Mimicry by Targeting the HIF-1/VEGFA Pathway in Hepatocellular Carcinoma. J Immunol Res. 2022; 2022:7318950. PMC: 9167126. DOI: 10.1155/2022/7318950. View

14.

Roderburg C, Luedde T . Circulating microRNAs as markers of liver inflammation, fibrosis and cancer. J Hepatol. 2014; 61(6):1434-7. DOI: 10.1016/j.jhep.2014.07.017. View

15.

Yang H, Fang F, Chang R, Yang L . MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor β receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma. Hepatology. 2013; 58(1):205-17. DOI: 10.1002/hep.26315. View

16.

Bi J, Zheng J, Li Q, Bao S, Yu X, Xu P . MicroRNA-181a-5p suppresses cell proliferation by targeting Egr1 and inhibiting Egr1/TGF-β/Smad pathway in hepatocellular carcinoma. Int J Biochem Cell Biol. 2018; 106:107-116. DOI: 10.1016/j.biocel.2018.11.011. View

17.

Abdalla M, Haj-Ahmad Y . Promising Candidate Urinary MicroRNA Biomarkers for the Early Detection of Hepatocellular Carcinoma among High-Risk Hepatitis C Virus Egyptian Patients. J Cancer. 2012; 3:19-31. PMC: 3245605. DOI: 10.7150/jca.3.19. View

18.

Wang Y, Tai Q, Zhang J, Kang J, Gao F, Zhong F . MiRNA-206 inhibits hepatocellular carcinoma cell proliferation and migration but promotes apoptosis by modulating cMET expression. Acta Biochim Biophys Sin (Shanghai). 2019; 51(3):243-253. DOI: 10.1093/abbs/gmy119. View

19.

Jin Q, Li X, Cao P . MicroRNA-26b Enhances the Radiosensitivity of Hepatocellular Carcinoma Cells by Targeting EphA2. Tohoku J Exp Med. 2016; 238(2):143-51. DOI: 10.1620/tjem.238.143. View

20.

Rupaimoole R, Calin G, Lopez-Berestein G, Sood A . miRNA Deregulation in Cancer Cells and the Tumor Microenvironment. Cancer Discov. 2016; 6(3):235-46. PMC: 4783232. DOI: 10.1158/2159-8290.CD-15-0893. View